We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$836M
AUM Growth
+$219M
Cap. Flow
+$188M
Cap. Flow %
22.5%
Top 10 Hldgs %
4.49%
Holding
1,220
New
441
Increased
247
Reduced
213
Closed
319

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.41M
2
AAP icon
Advance Auto Parts
AAP
+$4.15M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.96M
4
DLTR icon
Dollar Tree
DLTR
+$3.82M
5
MSFT icon
Microsoft
MSFT
+$3.74M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$2.82M
2
KO icon
Coca-Cola
KO
+$2.82M
3
GD icon
General Dynamics
GD
+$2.82M
4
ORCL icon
Oracle
ORCL
+$2.81M
5
HLNE icon
Hamilton Lane
HLNE
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Industrials 15.72%
3 Consumer Discretionary 15.68%
4 Healthcare 13.43%
5 Financials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPCE icon
1151
Virgin Galactic
SPCE
$325M
– –
-11,923
Closed -$101K
SPT icon
1152
Sprout Social
SPT
$500M
– –
-21,947
Closed -$783K
SPXC icon
1153
SPX Corp
SPXC
$11B
– –
-1,761
Closed -$250K
SSP icon
1154
E.W. Scripps
SSP
$271M
– –
-50,695
Closed -$159K
ST icon
1155
Sensata Technologies
ST
$6.75B
– –
-7,277
Closed -$272K
STNE icon
1156
StoneCo
STNE
$2.65B
– –
-133,461
Closed -$1.6M
STRA icon
1157
Strategic Education
STRA
$1.78B
– –
-9,216
Closed -$1.02M
SYM icon
1158
Symbotic
SYM
$5.28B
– –
-10,436
Closed -$367K
TBPH icon
1159
Theravance Biopharma
TBPH
$874M
– –
-18,154
Closed -$154K
TCMD icon
1160
Tactile Systems Technology
TCMD
$626M
– –
-21,642
Closed -$258K
TDG icon
1161
TransDigm Group
TDG
$71.9B
– –
-939
Closed -$1.2M
TDOC icon
1162
Teladoc Health
TDOC
$1.61B
– –
-31,446
Closed -$308K
TDS icon
1163
Telephone and Data Systems
TDS
$3.83B
– –
-25,798
Closed -$535K
TDY icon
1164
Teledyne Technologies
TDY
$30.2B
– –
-2,264
Closed -$878K
THG icon
1165
Hanover Insurance
THG
$7.68B
– –
-7,122
Closed -$893K
TITN icon
1166
Titan Machinery
TITN
$469M
– –
-12,000
Closed -$191K
TNDM icon
1167
Tandem Diabetes Care
TNDM
$1.18B
– –
-5,980
Closed -$241K
TNL icon
1168
Travel + Leisure Co
TNL
$4.68B
– –
-5,534
Closed -$249K
TOL icon
1169
Toll Brothers
TOL
$14.1B
– –
-9,772
Closed -$1.13M
TPL icon
1170
Texas Pacific Land
TPL
$27.4B
– –
-2,805
Closed -$687K
TT icon
1171
Trane Technologies
TT
$107B
– –
-759
Closed -$250K
TTD icon
1172
Trade Desk
TTD
$8.41B
– –
-4,236
Closed -$414K
TWST icon
1173
Twist Bioscience
TWST
$5.39B
– –
-14,905
Closed -$735K
UFPT icon
1174
UFP Technologies
UFPT
$1.92B
– –
-1,425
Closed -$376K
URBN icon
1175
Urban Outfitters
URBN
$6.22B
– –
-15,987
Closed -$656K
45 46
47
48 49

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q3 2024 Portfolio in Review

As of Q3 2024, Nebula Research & Development held 1,220 positions worth $836M, up 35% from $618M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

Nebula Research & Development deployed $188M of net new capital in Q3 2024, opening 441 new positions and adding to 247 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Travelers Companies, an estimated $2.39M trimmed.

  • Nebula Research & Development's largest Q3 2024 buy was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.
  • Nebula Research & Development added most to Dollar Tree in Q3 2024, an estimated $3.82M increase.
  • Nebula Research & Development's biggest Q3 2024 reduction was Travelers Companies, cutting an estimated $2.39M.
  • Nebula Research & Development fully exited Bank of America in Q3 2024, selling an estimated $2.82M.
  • Nebula Research & Development's ten largest holdings make up 4.5% of its $836M portfolio in Q3 2024.
  • Nebula Research & Development opened 441 new positions and closed 319 in Q3 2024.
  • Nebula Research & Development's portfolio value rose 35% quarter-over-quarter to $836M.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.